BIO.WA(BIO.WA)
BIO.WA
No analyst ratings available
No analyst price targets available for BIO.WA
Analyst coverage may not be available for this symbol
Earnings surprise history unavailable.
No recent analyst actions
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $266M | $285M |
| Low | $266M | $285M |
| High | $266M | $285M |
| EBITDA Avg | $54M | $58M |
| Low | $54M | $58M |
| High | $54M | $58M |
| EBIT Avg | $10M | $11M |
| Low | $10M | $11M |
| High | $10M | $11M |
| Net Income Avg | $12M | $22M |
| Low | $12M | $22M |
| High | $12M | $22M |
| EPS Avg | $0.14 | $0.26 |
| Low | $0.14 | $0.26 |
| High | $0.14 | $0.26 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q2 2027 | Q1 2029 | Q2 2029 | Q4 2029 | Q1 2030 | Q3 2030 | Q4 2030 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $50M | $53M | $37M | $45M | $72M | $76M | $45M |
| Low | $50M | $53M | $37M | $45M | $72M | $76M | $45M |
| High | $50M | $53M | $37M | $45M | $72M | $76M | $45M |
| EBITDA Avg | $10M | $11M | $7M | $9M | $15M | $15M | $9M |
| Low | $10M | $11M | $7M | $9M | $15M | $15M | $9M |
| High | $10M | $11M | $7M | $9M | $15M | $15M | $9M |
| EBIT Avg | $2M | $2M | $1M | $2M | $3M | $3M | $2M |
| Low | $2M | $2M | $1M | $2M | $3M | $3M | $2M |
| High | $2M | $2M | $1M | $2M | $3M | $3M | $2M |
| Net Income Avg | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — |
| EPS Avg | — | — | — | — | — | — | — |
| Low | — | — | — | — | — | — | — |
| High | — | — | — | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — | 1 / — |